Drug Type Small molecule drug |
Synonyms BRD 7389, BRD7389 |
Target |
Action inhibitors |
Mechanism RSK inhibitors(Ribosomal protein S6 kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H18N2O2 |
InChIKeyXASCINRGTHLHGM-UHFFFAOYSA-N |
CAS Registry376382-11-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Preclinical | United States | 09 Aug 2010 |